Not available
Quote | Adverum Biotechnologies Inc. (NASDAQ:ADVM)
Last: | $8.04 |
---|---|
Change Percent: | 0.97% |
Open: | $8.17 |
Close: | $8.04 |
High: | $8.38 |
Low: | $7.85 |
Volume: | 1,794,547 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Adverum Biotechnologies Inc. (NASDAQ:ADVM)
2024-05-09 17:34:55 ET More on Adverum Biotechnologies Adverum Biotechnologies a new buy at H.C. Wainwright on wet AMD gene therapy Seeking Alpha’s Quant Rating on Adverum Biotechnologies Historical earnings data for Adverum Biotechnologies Financial i...
- Phase 2 LUNA interim analysis to be presented at ASRS Annual Scientific Meeting on July 17 th , 2024 in Stockholm, Sweden - $193.3 million in cash, cash equivalents and short-term investments expected to fund operations into late 2025 REDWOOD CITY, Calif., May 09, 20...
Message Board Posts | Adverum Biotechnologies Inc. (NASDAQ:ADVM)
Subject | By | Source | When |
---|---|---|---|
$ADVM: Watching here at 0.70 now............ readytogooooooo | makinezmoney | investorshub | 01/30/2023 3:01:27 PM |
Adverum lays off 78 employees, bets it all | conix | investorshub | 07/08/2022 2:49:25 PM |
News but PPS not active premarket. | kzivann | investorshub | 01/04/2022 1:26:50 PM |
$ADVM chart on the mend | conix | investorshub | 08/26/2021 12:54:36 PM |
Form 4 - options granted for newly hired | TraderNeoMtl | investorshub | 06/04/2021 1:37:01 AM |
News, Short Squeeze, Breakout and More Instantly...
Adverum Biotechnologies Inc. Company Name:
ADVM Stock Symbol:
NASDAQ Market:
- Phase 2 LUNA interim analysis to be presented at ASRS Annual Scientific Meeting on July 17th, 2024 in Stockholm, Sweden - $193.3 million in cash...
- Phase 2 LUNA interim analysis to be presented at ASRS Annual Scientific Meeting on July 17 th , 2024 in Stockholm, Sweden - $193.3 million in cash, cash equivalents and short-term investments expected to fund operations into late 2025 REDWOOD CITY, Calif., May 09, 20...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...